Salem Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $937K | Hold |
2,897
| – | – | 0.74% | 34 |
|
|
2022
Q2 | $939K | Sell |
2,897
-397
| -12% | -$119K | 0.68% | 34 |
|
|
2022
Q1 | $943K | Hold |
3,294
| – | – | 0.53% | 38 |
|
|
2021
Q4 | $910K | Buy |
3,294
+100
| +3% | +$25.4K | 0.47% | 43 |
|
|
2021
Q3 | $738K | Sell |
3,194
-300
| -9% | -$74K | 0.4% | 47 |
|
|
2021
Q2 | $802K | Sell |
3,494
-800
| -19% | -$161K | 0.44% | 46 |
|
|
2021
Q1 | $802K | Sell |
4,294
-50
| -1% | -$9.78K | 0.48% | 43 |
|
|
2020
Q4 | $733K | Hold |
4,344
| – | – | 0.47% | 45 |
|
|
2020
Q3 | $643K | Sell |
4,344
-500
| -10% | -$77.4K | 0.47% | 43 |
|
|
2020
Q2 | $795K | Hold |
4,844
| – | – | 0.57% | 36 |
|
|
2020
Q1 | $672K | Hold |
4,844
| – | – | 0.56% | 41 |
|
|
2019
Q4 | $637K | Hold |
4,844
| – | – | 0.35% | 46 |
|
|
2019
Q3 | $542K | Sell |
4,844
-197
| -4% | -$21.9K | 0.31% | 48 |
|
|
2019
Q2 | $558K | Sell |
5,041
-517
| -9% | -$60.9K | 0.31% | 52 |
|
|
2019
Q1 | $721K | Buy |
5,558
+397
| +8% | +$48.3K | 0.39% | 44 |
|
|
2018
Q4 | $597K | Sell |
5,161
-232
| -4% | -$25.9K | 0.38% | 45 |
|
|
2018
Q3 | $579K | Sell |
5,393
-174
| -3% | -$17.4K | 0.31% | 48 |
|
|
2018
Q2 | $475K | Hold |
5,567
| – | – | 0.25% | 51 |
|
|
2018
Q1 | $431K | Hold |
5,567
| – | – | 0.23% | 54 |
|
|
2017
Q4 | $470K | Sell |
5,567
-500
| -8% | -$42.5K | 0.24% | 52 |
|
|
2017
Q3 | $519K | Hold |
6,067
| – | – | 0.27% | 52 |
|
|
2017
Q2 | $499K | Hold |
6,067
| – | – | 0.28% | 52 |
|
|
2017
Q1 | $510K | Hold |
6,067
| – | – | 0.28% | 50 |
|
|
2016
Q4 | $446K | Hold |
6,067
| – | – | 0.25% | 53 |
|
|
2016
Q3 | $487K | Hold |
6,067
| – | – | 0.27% | 52 |
|
|
2016
Q2 | $478K | Buy |
6,067
+617
| +11% | +$46.5K | 0.28% | 52 |
|
|
2016
Q1 | $392K | Sell |
5,450
-1,300
| -19% | -$98.4K | 0.22% | 54 |
|
|
2015
Q4 | $569K | Sell |
6,750
-400
| -6% | -$33.2K | 0.32% | 50 |
|
|
2015
Q3 | $598K | Hold |
7,150
| – | – | 0.35% | 49 |
|
|
2015
Q2 | $597K | Hold |
7,150
| – | – | 0.31% | 49 |
|
|
2015
Q1 | $519K | Hold |
7,150
| – | – | 0.26% | 51 |
|
|
2014
Q4 | $493K | Hold |
7,150
| – | – | 0.23% | 54 |
|
|
2014
Q3 | $464K | Hold |
7,150
| – | – | 0.22% | 54 |
|
|
2014
Q2 | $445K | Hold |
7,150
| – | – | 0.2% | 57 |
|
|
2014
Q1 | $421K | Hold |
7,150
| – | – | 0.18% | 59 |
|
|
2013
Q4 | $365K | Hold |
7,150
| – | – | 0.16% | 60 |
|
|
2013
Q3 | $360K | Hold |
7,150
| – | – | 0.17% | 61 |
|
|
2013
Q2 | $351K | Buy |
+7,150
| New | +$389K | 0.17% | 61 |
|
Other funds holding LLY
Salem Capital Management's LLY Position: Q3 2022 in Review
Salem Capital Management held its Eli Lilly (LLY) position steady in Q3 2022 at 2,897 shares worth $937K. The position accounts for 0.74% of the portfolio, ranked #34.
Salem Capital Management first reported a position in LLY in Q2 2013 and has held it in 38 quarters since. The position peaked at $943K in Q1 2022. 2,484 funds tracked by Wall St. Rank hold LLY as of Q3 2022.
- Salem Capital Management held 2,897 shares of Eli Lilly worth $937K as of Q3 2022.
- Salem Capital Management left its Eli Lilly share count unchanged in Q3 2022.
- Eli Lilly made up 0.74% of Salem Capital Management's portfolio in Q3 2022, its #34 holding.
- Salem Capital Management first reported a position in Eli Lilly in Q2 2013 and has held it in 38 quarters since.
- Salem Capital Management's Eli Lilly position peaked at $943K in Q1 2022.
- 2,484 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.
Based on Salem Capital Management's 13F filing for Q3 2022, filed 29 Nov 2022.